{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T22:01:44Z","timestamp":1790114504058,"version":"4.0.1"},"reference-count":33,"publisher":"The Endocrine Society","issue":"5","license":[{"start":{"date-parts":[[2022,3,18]],"date-time":"2022-03-18T00:00:00Z","timestamp":1647561600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100010269","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["106995\/Z\/15\/Z"],"award-info":[{"award-number":["106995\/Z\/15\/Z"]}],"id":[{"id":"10.13039\/100010269","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["NF-SI-0514\u201310091"],"award-info":[{"award-number":["NF-SI-0514\u201310091"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013373","name":"NIHR Oxford Biomedical Research Centre","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013373","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,5,1]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Autosomal dominant hypocalcemia type 1 (ADH1) is a disorder of extracellular calcium homeostasis caused by germline gain-of-function mutations of the calcium-sensing receptor (CaSR). More than 35% of ADH1 patients have intracerebral calcifications predominantly affecting the basal ganglia. The clinical consequences of such calcifications remain to be fully characterized, although the majority of patients with these calcifications are considered to be asymptomatic. We report a 20-year-old female proband with a severe form of ADH1 associated with recurrent hypocalcemic and hypercalcemic episodes, persistent childhood hyperphosphatemia, and a low calcium\/phosphate ratio. From the age of 18 years, she had experienced recurrent myoclonic jerks affecting the upper limbs that were not associated with epileptic seizures, extra-pyramidal features, cognitive impairment, or alterations in serum calcium concentrations. Computed tomography (CT) scans revealed calcifications of the globus pallidus regions of the basal ganglia bilaterally, and also the frontal lobes at the gray-white matter junction, and posterior horn choroid plexuses. The patient\u2019s myoclonus resolved following treatment with levetiracetam. CASR mutational analysis identified a reported germline gain-of-function heterozygous missense mutation, c.2363T&amp;gt;G; p.(Phe788Cys), which affects an evolutionarily conserved phenylalanine residue located in transmembrane domain helix 5 of the CaSR protein. Analysis of the cryo-electron microscopy CaSR structure predicted the wild-type Phe788 residue to form interactions with neighboring phenylalanine residues, which likely maintain the CaSR in an inactive state. The p.(Phe788Cys) mutation was predicted to disrupt these interactions, thereby leading to CaSR activation. These findings reveal myoclonus as a novel finding in an ADH1 patient with intracerebral calcifications.<\/jats:p>","DOI":"10.1210\/jendso\/bvac042","type":"journal-article","created":{"date-parts":[[2022,3,18]],"date-time":"2022-03-18T17:18:43Z","timestamp":1647623923000},"source":"Crossref","is-referenced-by-count":10,"title":["Autosomal Dominant Hypocalcemia Type 1 (ADH1) Associated With Myoclonus and Intracerebral Calcifications"],"prefix":"10.1210","volume":"6","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0748-2300","authenticated-orcid":false,"given":"Marianne S","family":"Elston","sequence":"first","affiliation":[{"name":"Waikato Clinical Campus, University of Auckland, Hamilton 3240, New Zealand"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7293-254X","authenticated-orcid":false,"given":"Taha","family":"Elajnaf","sequence":"additional","affiliation":[{"name":"Nuffield Department of Women\u2019s & Reproductive Health, University of Oxford, Oxford OX3 9DU, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2975-5170","authenticated-orcid":false,"given":"Fadil M","family":"Hannan","sequence":"additional","affiliation":[{"name":"Nuffield Department of Women\u2019s & Reproductive Health, University of Oxford, Oxford OX3 9DU, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1438-3220","authenticated-orcid":false,"given":"Rajesh V","family":"Thakker","sequence":"additional","affiliation":[{"name":"Academic Endocrine Unit, Radcliffe Department of Medicine, University of Oxford, Oxford OX3 7LJ, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","published-online":{"date-parts":[[2022,3,18]]},"reference":[{"issue":"15","key":"2022040717023169800_CIT0001","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1056\/NEJM199610103351505","article-title":"A familial syndrome of hypocalcemia with hypercalciuria due to mutations in the calcium-sensing receptor","volume":"335","author":"Pearce","year":"1996","journal-title":"N Engl J Med."},{"issue":"12","key":"2022040717023169800_CIT0002","doi-asserted-by":"crossref","first-page":"2768","DOI":"10.1093\/hmg\/dds105","article-title":"Identification of 70 calcium-sensing receptor mutations in hyper- and hypo-calcaemic patients: evidence for clustering of extracellular domain mutations at calcium-binding sites","volume":"21","author":"Hannan","year":"2012","journal-title":"Hum Mol Genet."},{"issue":"1","key":"2022040717023169800_CIT0003","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1038\/s41574-018-0115-0","article-title":"The calcium-sensing receptor in physiology and in calcitropic and noncalcitropic diseases","volume":"15","author":"Hannan","year":"2018","journal-title":"Nat Rev Endocrinol."},{"issue":"3","key":"2022040717023169800_CIT0004","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/j.cell.2008.08.040","article-title":"Anatomical profiling of G protein-coupled receptor expression","volume":"135","author":"Regard","year":"2008","journal-title":"Cell."},{"issue":"9","key":"2022040717023169800_CIT0005","doi-asserted-by":"crossref","first-page":"3355","DOI":"10.1172\/JCI57407","article-title":"PTH-independent regulation of blood calcium concentration by the calcium-sensing receptor","volume":"122","author":"Loupy","year":"2012","journal-title":"J Clin Invest."},{"issue":"6","key":"2022040717023169800_CIT0006","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1016\/j.ajhg.2020.04.006","article-title":"Familial hypocalciuric hypercalcemia type 1 and autosomal-dominant hypocalcemia type 1: prevalence in a large healthcare population","volume":"106","author":"Dershem","year":"2020","journal-title":"Am J Hum Genet."},{"key":"2022040717023169800_CIT0007","doi-asserted-by":"crossref","first-page":"17055","DOI":"10.1038\/nrdp.2017.55","article-title":"Hypoparathyroidism","volume":"3","author":"Mannstadt","year":"2017","journal-title":"Nat Rev Dis Primers."},{"issue":"26","key":"2022040717023169800_CIT0008","doi-asserted-by":"crossref","first-page":"2476","DOI":"10.1056\/NEJMoa1300253","article-title":"Mutations affecting G-protein subunit alpha11 in hypercalcemia and hypocalcemia","volume":"368","author":"Nesbit","year":"2013","journal-title":"N Engl J Med."},{"issue":"6","key":"2022040717023169800_CIT0009","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1111\/j.1365-2265.2011.04142.x","article-title":"Activating mutations in the calcium-sensing receptor: genetic and clinical spectrum in 25 patients with autosomal dominant hypocalcemia - a German survey","volume":"75","author":"Raue","year":"2011","journal-title":"Clin Endocrinol (Oxf)."},{"issue":"12","key":"2022040717023169800_CIT0010","doi-asserted-by":"crossref","first-page":"4583","DOI":"10.1210\/jcem.85.12.7035","article-title":"Comparison of hypocalcemic hypercalciuria between patients with idiopathic hypoparathyroidism and those with gain-of-function mutations in the calcium-sensing receptor: is it possible to differentiate the two disorders?","volume":"85","author":"Yamamoto","year":"2000","journal-title":"J Clin Endocrinol Metab."},{"issue":"2","key":"2022040717023169800_CIT0011","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1056\/NEJMc2034981","article-title":"PTH Infusion for Seizures in Autosomal Dominant Hypocalcemia Type 1","volume":"385","author":"Sastre","year":"2021","journal-title":"N Engl J Med."},{"issue":"11","key":"2022040717023169800_CIT0012","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1111\/apa.12743","article-title":"Activating calcium-sensing receptor gene variants in children: a case study of infant hypocalcemia and literature review","volume":"103","author":"Thim","year":"2014","journal-title":"Acta Paediatr."},{"issue":"6","key":"2022040717023169800_CIT0013","doi-asserted-by":"crossref","first-page":"e234391","DOI":"10.1136\/bcr-2020-234391","article-title":"Autosomal dominant hypocalcemia: identification of two novel variants of CASR gene","volume":"13","author":"Gomes","year":"2020","journal-title":"BMJ Case Rep."},{"key":"2022040717023169800_CIT0014","doi-asserted-by":"crossref","first-page":"200","DOI":"10.3389\/fendo.2018.00200","article-title":"Identification and functional characterization of a novel mutation in the human calcium-sensing receptor that co-segregates with autosomal-dominant hypocalcemia","volume":"9","author":"Rasmussen","year":"2018","journal-title":"Front Endocrinol (Lausanne)."},{"issue":"9","key":"2022040717023169800_CIT0015","doi-asserted-by":"crossref","first-page":"2259","DOI":"10.1097\/01.ASN.0000025781.16723.68","article-title":"Functional characterization of a calcium-sensing receptor mutation in severe autosomal dominant hypocalcemia with a Bartter-like syndrome","volume":"13","author":"Vargas-Poussou","year":"2002","journal-title":"J Am Soc Nephrol."},{"issue":"9334","key":"2022040717023169800_CIT0016","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1016\/S0140-6736(02)09842-2","article-title":"Association between activating mutations of calcium-sensing receptor and Bartter\u2019s syndrome","volume":"360","author":"Watanabe","year":"2002","journal-title":"Lancet."},{"issue":"1","key":"2022040717023169800_CIT0017","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1002\/ajmg.a.31054","article-title":"Severe hypocalcemia due to a de novo mutation in the fifth transmembrane domain of the calcium-sensing receptor","volume":"140","author":"Mora","year":"2006","journal-title":"Am J Med Genet A."},{"issue":"2","key":"2022040717023169800_CIT0018","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1002\/jbm4.10019","article-title":"Serum calcium to phosphorous (Ca\/P) ratio is a simple, inexpensive, and accurate tool in the diagnosis of primary hyperparathyroidism","volume":"2","author":"Madeo","year":"2018","journal-title":"JBMR Plus."},{"issue":"5","key":"2022040717023169800_CIT0019","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/s11940-016-0404-7","article-title":"Myoclonus: pathophysiology and treatment options","volume":"18","author":"Levy","year":"2016","journal-title":"Curr Treat Options Neurol."},{"issue":"7","key":"2022040717023169800_CIT0020","first-page":"2497","article-title":"Familial hypoparathyroidism: identification of a novel gain of function mutation in transmembrane domain 5 of the calcium-sensing receptor","volume":"83","author":"Watanabe","year":"1998","journal-title":"J Clin Endocrinol Metab."},{"issue":"7867","key":"2022040717023169800_CIT0021","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1038\/s41586-021-03691-0","article-title":"Asymmetric activation of the calcium-sensing receptor homodimer","volume":"595","author":"Gao","year":"2021","journal-title":"Nature."},{"issue":"4","key":"2022040717023169800_CIT0022","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/j.clineuro.2004.12.017","article-title":"Cortical myoclonus due to hypocalcemia 12 years after thyroidectomy","volume":"108","author":"Ueno","year":"2006","journal-title":"Clin Neurol Neurosurg."},{"issue":"11","key":"2022040717023169800_CIT0023","doi-asserted-by":"crossref","first-page":"2251","DOI":"10.1007\/s10072-019-03998-x","article-title":"Basal ganglia calcifications (Fahr\u2019s syndrome): related conditions and clinical features","volume":"40","author":"Donzuso","year":"2019","journal-title":"Neurol Sci."},{"issue":"7","key":"2022040717023169800_CIT0024","doi-asserted-by":"crossref","first-page":"1900","DOI":"10.1210\/clinem\/dgab162","article-title":"Basal ganglia calcification is associated with local and systemic metabolic mechanisms in adult hypoparathyroidism","volume":"106","author":"Zavatta","year":"2021","journal-title":"J Clin Endocrinol Metab."},{"issue":"8","key":"2022040717023169800_CIT0025","doi-asserted-by":"crossref","first-page":"2221","DOI":"10.1007\/s00415-020-09821-4","article-title":"Cortical myoclonus and epilepsy in a family with a new SLC20A2 mutation","volume":"267","author":"Coppola","year":"2020","journal-title":"J Neurol."},{"issue":"5","key":"2022040717023169800_CIT0026","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/0006-3223(94)90038-8","article-title":"Neuropsychiatric disorders, myoclonus, and dystonia in calcification of basal ganglia pathways","volume":"35","author":"Lauterbach","year":"1994","journal-title":"Biol Psychiatry."},{"issue":"1","key":"2022040717023169800_CIT0027","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1055\/s-0035-1554979","article-title":"Novel mutation in the CASR Gene (p.Leu123Ser) in a case of autosomal dominant hypocalcemia","volume":"4","author":"Regala","year":"2015","journal-title":"J Pediatr Genet."},{"key":"2022040717023169800_CIT0028","doi-asserted-by":"crossref","first-page":"2329048X","DOI":"10.1177\/2329048X19876199","article-title":"intractable generalized epilepsy and autosomal dominant hypocalcemia: a case report","volume":"6","author":"Rossi","year":"2019","journal-title":"Child Neurol Open."},{"issue":"18","key":"2022040717023169800_CIT0029","doi-asserted-by":"crossref","first-page":"2077","DOI":"10.2169\/internalmedicine.52.8375","article-title":"Extrapyramidal symptoms and advanced calcification of the basal ganglia in a patient with autosomal dominant hypocalcemia","volume":"52","author":"Kurozumi","year":"2013","journal-title":"Intern Med."},{"issue":"6","key":"2022040717023169800_CIT0030","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1002\/mdc3.13009","article-title":"A novel phenotype associated with CaSR-related familial brain calcifications","volume":"7","author":"Scannapieco","year":"2020","journal-title":"Mov Disord Clin Pract."},{"issue":"1","key":"2022040717023169800_CIT0031","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1007\/s00223-020-00729-9","article-title":"Role of phosphate in biomineralization","volume":"108","author":"Bhadada","year":"2021","journal-title":"Calcif Tissue Int."},{"key":"2022040717023169800_CIT0032","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.jns.2018.03.014","article-title":"Inorganic phosphorus (Pi) in CSF is a biomarker for SLC20A2-associated idiopathic basal ganglia calcification (IBGC1)","volume":"388","author":"Hozumi","year":"2018","journal-title":"J Neurol Sci."},{"issue":"8","key":"2022040717023169800_CIT0033","doi-asserted-by":"crossref","first-page":"1865","DOI":"10.1016\/j.ajpath.2018.04.010","article-title":"Mice knocked out for the primary brain calcification-associated gene slc20a2 show unimpaired prenatal survival but retarded growth and nodules in the brain that grow and calcify over time","volume":"188","author":"Jensen","year":"2018","journal-title":"Am J Pathol."}],"container-title":["Journal of the Endocrine Society"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jes\/advance-article-pdf\/doi\/10.1210\/jendso\/bvac042\/42953363\/bvac042.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jes\/article-pdf\/6\/5\/bvac042\/43298318\/bvac042.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jes\/article-pdf\/6\/5\/bvac042\/43298318\/bvac042.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,29]],"date-time":"2023-01-29T13:40:43Z","timestamp":1674999643000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jes\/article\/doi\/10.1210\/jendso\/bvac042\/6550632"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,18]]},"references-count":33,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2022,5,1]]}},"URL":"https:\/\/doi.org\/10.1210\/jendso\/bvac042","relation":{},"ISSN":["2472-1972"],"issn-type":[{"value":"2472-1972","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2022,5,1]]},"published":{"date-parts":[[2022,3,18]]},"article-number":"bvac042"}}